NBEAL2 is required for neutrophil and NK cell function and pathogen defense

Journal of Clinical Investigation

Volumn 127, Issue 9, 2017, Pages 3521-3526

  Sowerby, John M ^a   Thomas, David C ^a   Clare, Simon ^b   Espéli, Marion ^a,c   Guerrero, Jose A ^d,e   Hoenderdos, Kim ^a   Harcourt, Katherine ^b   Marsden, Morgan ^f   Abdul Karim, Juneid ^f   Clement, Mathew ^f   Antrobus, Robin ^g   Umrania, Yagnesh ^g   Barton, Philippa R ^g   Flint, Shaun M ^a   Juss, Jatinder K ^a   Condliffe, Alison M ^a   Lyons, Paul A ^a   Humphreys, Ian R ^f   Chilvers, Edwin R ^a   Ouwehand, Willem H ^b,d,e   Dougan, Gordon ^a,b   Smith, Kenneth G C ^a   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c Universite Paris Sud   (France)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e NHS BLOOD AND TRANSPLANT   (United Kingdom)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; NBEAL2 PROTEIN, HUMAN; PLASMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEGRANULATION; GENE; IMMUNE SYSTEM; IMMUNITY; MOUSE; NATURAL KILLER CELL; NBEAL2 GENE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY BURST; STAPHYLOCOCCUS AUREUS; ANIMAL; CYTOSOL; GENETICS; GRAY PLATELET SYNDROME; HUMAN; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; METABOLISM; MUTATION; STAPHYLOCOCCUS INFECTION; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; BLOOD PROTEINS; CYTOSOL; GRAY PLATELET SYNDROME; HUMANS; IMMUNE SYSTEM; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; MICE; MICE, KNOCKOUT; MUTATION; NADPH OXIDASE; NEUTROPHILS; PHENOTYPE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 85028915075     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI91684     Document Type: Article

References (27)

1. Albers CA, et al. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nat Genet. 2011;43(8):735-737.
2. Gunay-Aygun M, et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Nat Genet. 2011;43(8):732-734.
3. Kahr WH, et al. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet. 2011;43(8):738-740.
4. Guerrero JA, et al. Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice. Blood. 2014;124(24):3624-3635.
5. Deppermann C, et al. Gray platelet syndrome defective thrombo-inflammation in Nbeal2-deficient mice. J Clin Invest. 2013;123(8): 3331-3342.
6. Kahr WH, et al. Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. Blood. 2013;122(19):3349-3358.
7. Cullinane AR, Schäffer AA, Huizing M. The BEACH is hot: a LYST of emerging roles for BEACH-domain containing proteins in human disease. Traffic. 2013;14(7):749-766.
8. Westbroek W, et al. Cellular defects in Chediak-Higashi syndrome correlate with the molecular genotype and clinical phenotype. J Invest Dermatol. 2007;127(11):2674-2677.
9. Ward DM, Shiflett SL, Kaplan J. Chediak-Higashi syndrome: a clinical and molecular view of a rare lysosomal storage disorder. Curr Mol Med. 2002;2(5):469-477.
10. Lopez-Herrera G, et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet. 2012;90(6):986-1001.
11. Lo B, et al. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science. 2015;349(6246):436-440.
12. Drouin A, et al. Newly recognized cellular abnormalities in the gray platelet syndrome. Blood. 2001;98(5):1382-1391.
13. Kahr WH, Dror Y. Gray platelet syndrome: macrothrombocytopenia with deficient α-granules. Blood. 2012;120(13):2543.
14. Rensing-Ehl A, et al. Gray platelet syndrome can mimic autoimmune lymphoproliferative syndrome. Blood. 2015;126(16):1967-1969.
15. Gunay-Aygun M, et al. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood. 2010;116(23):4990-5001.
16. White JG, Brunning RD. Neutrophils in the gray platelet syndrome. Platelets. 2004;15(5):333-340.
17. Chedani H, Dupuy E, Massé JM, Cramer EM. Neutrophil secretory defect in the gray platelet syndrome: a new case. Platelets. 2006;17(1):14-19.
18. Rorvig S, Ostergaard O, Heegaard NH, Borregaard N. Proteome profiling of human neutrophil granule subsets, secretory vesicles, and cell membrane: correlation with transcriptome profiling of neutrophil precursors. J Leukoc Biol. 2013;94(4):711-721.
19. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997;89(10):3503-3521.
20. Harrison JE, Schultz J. Studies on the chlorinating activity of myeloperoxidase. J Biol Chem. 1976;251(5):1371-1374.
21. Nauseef WM, Metcalf JA, Root RK. Role of myeloperoxidase in the respiratory burst of human neutrophils. Blood. 1983;61(3):483-492.
22. Obermeier H, Sellmayer A, Danesch U, Aepfelbacher M. Cooperative effects of interferon-gamma on the induction of NADPH oxidase by retinoic acid or 1,25(OH)2-vitamin D3 in monocytic U937 cells. Biochim Biophys Acta. 1995;1269(1):25-31.
23. Sumi D, Hayashi T, Matsui-Hirai H, Jacobs AT, Ignarro LJ, Iguchi A. 17beta-estradiol inhibits NADPH oxidase activity through the regulation of p47phox mRNA and protein expression in THP-1 cells. Biochim Biophys Acta. 2003;1640(2-3):113-118.
24. Verdrengh M, Tarkowski A. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun. 1997;65(7):2517-2521.
25. von Köckritz-Blickwede M, et al. Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. Am J Pathol. 2008;173(6):1657-1668.
26. Tay CH, Welsh RM. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol. 1997;71(1):267-275.
27. Stacey MA, Marsden M, Wang EC, Wilkinson GW, Humphreys IR. IL-10 restricts activation-induced death of NK cells during acute murine cytomegalovirus infection. J Immunol. 2011;187(6):2944-2952.